MedTrace Logo

CoolSculpting the Flanks

NCT03304925 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2020-08-18

No results posted yet for this study

Summary

Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flanks.

Conditions

  • Body Fat Disorder

Interventions

DEVICE

The ZELTIQ System

The CoolSculpting machine will be used to perform the treatments.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Principal Investigators

  • Kerrie Jiang, NP · Zeltiq Aesthetics

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-25
Primary Completion
2022-08-31
Completion
2022-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03304925 on ClinicalTrials.gov